The JPMorgan CEO said he plans to stay on the job during fight with cancer.
The type of throat cancer Jamie Dimon has is curable in as many as 90 percent of cases with a treatment regimen that poses challenges for his demanding work schedule as chairman and chief executive of JPMorgan Chase & Co.
Dimon, 58, said he will continue running the biggest U.S. bank by assets “as normal” while he undergoes radiation and chemotherapy for about eight weeks at New York’s Memorial Sloan Kettering Cancer Center.
That may be hard to do, doctors said. A standard regimen includes high-energy X-rays for about 15 minutes once a day five days a week and infusions with drugs such as cisplatin once every week to three weeks, said Robert Haddad, disease center leader for the head-neck oncology program at Dana-Farber Cancer Institute in Boston.
“The challenge with this treatment is the fact that it’s a daily treatment,” Haddad said in an interview. “Logistically, it’s quite demanding because he has to go to the cancer center every day, five days a week, for seven weeks.”
After three or four weeks of treatment, it’s usually more difficult to work full-time, though it’s possible, said Haddad, who isn’t involved in Dimon’s case.
“Most people can continue to work to some degree, but not necessarily on a full-time schedule, especially someone in Jamie’s position, with the demands of his job,” he said.
A spokeswoman for Memorial Sloan Kettering declined to comment.
Dimon called his prognosis “excellent” and said the cancer was caught quickly. When throat tumors are spotted early, the cure rate can be as high as 90 percent, said Christopher Nutting, an oncologist at the Royal Marsden in London, Europe’s largest cancer center.
“He’s quite young in the context of this condition,” Nutting said.
Throat cancer is a catchall term used to describe any tumor that affects the back of the tongue, roof of the mouth, tonsils and the back wall of the throat.
More than 70 percent of U.S. cancer cases in this area of the throat are the result of infection with human papillomavirus, according to the Centers for Disease Control and Prevention in Atlanta.